SCHEMBL1008670

SCHEMBL1008670

CCC(C)C(N)(N)N=C=N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28202715 0.78
SCHEMBL17004047 0.74
Hydrochloric Acid SCHEMBL5862017 0.73
SCHEMBL7035849 0.68
SCHEMBL4768341 0.67
Hydrochloric Acid SCHEMBL3106051 0.67
SCHEMBL7021307 0.65
SCHEMBL19210876 0.65
Hydrochloric Acid SCHEMBL8692978 0.64
SCHEMBL6930775 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420556-B1 MULTISTAGE REACTION FOR HYPOTENSIVE AGENTS OR CARDIOTONIC AGENTS THE PROCTER & GAMBLE COMPANY 2002-07-16 US claimed
WO-2000035860-A2 ACYL ISOTHIOCYANATE RESINS AND THEIR USE IN SOLID-SUPPORTED SYNTHESIS OF GUANIDINES THE PROCTER & GAMBLE COMPANY (US) 2000-06-22 WO claimed
EP-0373956-B1 Nucleotide probes ORTHO DIAGNOSTIC SYSTEMS INC (US) 1995-07-26 EP claimed
EP-3362089-B1 IMMUNOGENIC COMPOSITIONS AGAINST S. AUREUS SANOFI PASTEUR (FR) 2023-12-06 EP disclosed
US-10772946-B2 Immunogenic compositions against S. aureus SANOFI PASTEUR (FR) 2020-09-15 US disclosed
US-20180280491-A1 IMMUNOGENIC COMPOSITIONS AGAINST S. AUREUS SANOFI PASTEUR (FR) 2018-10-04 US disclosed
WO-2011031284-A1 POLYMERIC CARRIER COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS, METHODS OF MAKING AND USING THE SAME PHARMAIN CORPORATION (US) 2011-03-17 WO disclosed
US-20110044968-A1 COMPOSITIONS FOR TREATMENT WITH METALLOPEPTIDASES, METHODS OF MAKING AND USING THE SAME Pharmal N Corporation (US) 2011-02-24 US disclosed
EP-1478406-B1 COMPOSITIONS FOR DELIVERY OF THERAPEUTICS AND OTHER MATERIALS, AND METHODS OF MAKING AND USING THE SAME PHARMAIN CORP (US) 2011-01-05 EP disclosed
US-7790140-B2 Compositions for delivery of therapeutics and other materials, and methods of making and using the same PHARMAIN CORPORATION (US) 2010-09-07 US disclosed
US-20100069293-A1 POLYMERIC CARRIER COMPOSITIONS FOR DELIVERY OF ACTIVE AGENTS, METHODS OF MAKING AND USING THE SAME PHARMAIN CORPORATION (US) 2010-03-18 US disclosed
WO-2005112977-A2 COMPOSITIONS FOR TREATMENT WITH GLUCAGON-LIKE PEPTIDE, AND METHODS OF MAKING AND USING THE SAME PHARMAIN, LTD. (US) 2005-12-01 WO disclosed
US-20050260259-A1 Compositions for treatment with glucagon-like peptide, and methods of making and using the same PHARMAIN CORPORATION 2005-11-24 US disclosed
EP-1478406-A1 COMPOSITIONS FOR DELIVERY OF THERAPEUTICS AND OTHER MATERIALS, AND METHODS OF MAKING AND USING THE SAME Pharmain, Ltd. (US) 2004-11-24 EP disclosed
WO-2003072143-A9 COMPOSITIONS FOR DELIVERY OF THERAPEUTICS AND OTHER MATERIALS, AND METHODS OF MAKING AND USING THE SAME PHARMAIN LTD (US) 2004-03-04 WO disclosed
US-20030224974-A1 Compositions for delivery of therapeutics and other materials, and methods of making and using the same PHARMAIN CORPORATION 2003-12-04 US disclosed
WO-2003072143-A1 COMPOSITIONS FOR DELIVERY OF THERAPEUTICS AND OTHER MATERIALS, AND METHODS OF MAKING AND USING THE SAME PHARMAIN, LTD. (US) 2003-09-04 WO disclosed
EP-0808181-B1 PROCESS FOR THE COATING OF OBJECTS WITH HYALURONIC ACID, DERIVATIVES THEREOF, AND SEMISYNTHETIC POLYMERS FIDIA ADVANCED BIOPOLYMERS SRL (IT) 2002-06-19 EP disclosed
US-6129956-A REACTING A HYALURONIC ACIDS OR SEMISYNTHETIC POLYMER WITH A SILOXY COUPLING AGENT IN PRESENCE OF CONDENSING BIFUNCTIONAL AGENT TO FROM A REACTION PRODUCT, COATING PLASMA TREATED SURFACE WITH REACTION PRODUCT TO REACT WITH SURFACE FIDIA ADVANCED BIOPLYMERS, SRL (IT) 2000-10-10 US disclosed
US-5496872-A Adhesive compositions for surgical use IMEDEX (FR) 1996-03-05 US disclosed